Deutsche Bank Aktiengesellschaft Reiterates Buy Rating for CVS Group (LON:CVSG)

CVS Group (LON:CVSG)‘s stock had its “buy” rating restated by stock analysts at Deutsche Bank Aktiengesellschaft in a report issued on Monday,London Stock Exchange reports. They presently have a GBX 1,700 price objective on the stock. Deutsche Bank Aktiengesellschaft’s price objective would suggest a potential upside of 36.22% from the stock’s current price.

Several other research firms have also issued reports on CVSG. Berenberg Bank reissued a “buy” rating and set a GBX 2,000 price objective on shares of CVS Group in a research note on Thursday. Jefferies Financial Group lowered shares of CVS Group to a “hold” rating and cut their target price for the stock from GBX 1,420 to GBX 1,350 in a research report on Thursday, July 9th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of GBX 1,710.

CVS Group Stock Up 4.8%

CVSG stock opened at GBX 1,248 on Monday. The stock has a 50-day simple moving average of GBX 1,222.74 and a two-hundred day simple moving average of GBX 1,246.87. CVS Group has a twelve month low of GBX 1,062 and a twelve month high of GBX 1,648. The firm has a market capitalization of £863.62 million, a PE ratio of 18.11, a PEG ratio of 1.77 and a beta of 1.06. The company has a quick ratio of 0.90, a current ratio of 1.07 and a debt-to-equity ratio of 92.34.

CVS Group announced that its board has approved a share buyback plan on Tuesday, May 26th that permits the company to buyback 0 outstanding shares. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are typically an indication that the company’s leadership believes its stock is undervalued.

Insiders Place Their Bets

In related news, insider Scott Morrison purchased 987 shares of CVS Group stock in a transaction dated Wednesday, May 27th. The stock was purchased at an average cost of GBX 1,270 per share, for a total transaction of £12,534.90. Company insiders own 1.43% of the company’s stock.

CVS Group Company Profile

CVS Group is a leading provider of veterinary services, operating in the UK and Australia, listed on the Main Market of the London Stock Exchange. CVS is focused on providing high-quality clinical services to its clients and their animals, with outstanding and dedicated clinical teams and support colleagues at the core of its strategy.

The Group operates from over 475 veterinary practices across its two territories, including specialist referral hospitals and dedicated out-of-hours sites. Alongside the core Veterinary Practices division, CVS operates Laboratories (providing diagnostic services to CVS and third-parties) and an online retail business (“Animed Direct”).

The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and c.3,300 nurses.